Loading...

Pfizer Inc.

PFE•NYSE
Healthcare
Drug Manufacturers - General
$27.00
$0.33(1.24%)
U.S. Market opens in 15h 23m

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap153.5B
P/E Ratio19.75
EPS (TTM)$1.36
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$25.57
3 Months$28.17
1 Year Target$26.26

PFE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pfizer Inc. (PFE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.75 and a market capitalization of 153.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.16%
5-Day Change
-1.28%
1-Month Change
0.07%
3-Month Change
5.19%
6-Month Change
8.97%
Year-to-Date (YTD) Change
8.35%
1-Year Change
18.44%
3-Year Change
-32.40%
5-Year Change
-30.25%
All-Time (Max) Change
6181.28%

Contact Information

https://www.pfizer.com
212 733 2323
66 Hudson Boulevard East, New York City, NY, 10001-2192

Company Facts

81,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions